Skip to content

Cholera vaccination as a model to measure the inflammatory response in the gut: A case of modulation with a Lactobacillus plantarum K8 lysate

Cholera vaccination as a model to measure the inflammatory response in the gut: A case of modulation with a Lactobacillus plantarum K8 lysate

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002589
Enrollment
50
Registered
2017-12-13
Start date
2017-09-12
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : On Visit 1 (day 0), subject who voluntarily signs on the written informed consent is reviewed according to inclusion-exclusion criteria. Selected subject is randomly allocated to

Sponsors

Ewha Womans University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agrees to participate and sign in informed consent form 2) 20 years= Age = 50 years 3) Men 4) Healthy bowel habit 5) Availability of internet connection 6) Smart phone user

Exclusion criteria

Exclusion criteria: 1) Previous cholera vaccination. 2) Other vaccination in the past 1 month. 3) Acute gastroenteritis in the past 2 months. 4) Use of antibiotics in the past 2 months. 5) Hypersensitivity to the vaccine, to formaldehyde, to any of the excipients (sodium salts) or to probiotics. 6) Disease of GI tract (constipation, diarrhea, IBD, etc), liver, gall bladder, kidneys, thyroid gland. 7) Immune-compromised. 8) Use of immunosuppressive drugs. 9) Drug abuse, and not willing/able to stop this during the study. 10) Continuous consumption of probiotics within 2 weeks prior to the study. 11) Excessive alcohol usage (140 g/week, about 3.5 bottles/week or 4 glasses/day as soju). 12) Participating in another clinical trial within 12 weeks prior to or during the study. 13) Visiting a country affected by cholera in the past 1 month.

Design outcomes

Primary

MeasureTime frame
Fecal calprotectin level ;Cholera toxin-specific antibody level in plasma

Secondary

MeasureTime frame
Local and systemic inflammatory responses;Fecal microbiota;Bristol stool scale

Countries

Korea, Republic of

Contacts

Public ContactMinyoung Park

Ewha Womans University

hanabi_223@hanmail.net+82-2-3277-3087

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 10, 2026